STEPHEN BURLEY was named as co-program leader of the Cancer Pharmacology Research Program at Rutgers Cancer Institute of New Jersey.
Burley will work with co-program leader X.F. Steven Zheng, a university professor at Rutgers Robert Wood Johnson Medical School, in determining the mode of action and mechanism of resistance to anti-cancer agents and developing novel concepts and strategies for cancer treatment.
Burley has been a full research member of Rutgers Cancer Institute since 2013. He is the director of the Center for Integrative Proteomics Research, founding director of the Institute for Quantitative Biomedicine, and a distinguished professor of chemistry and chemical biology in the School of Arts and Sciences at Rutgers University. He also serves as director of the Research Collaboratory Structural Bioinformatics Protein Data Bank.
